Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 USD | +6.60% | +6.60% | +19.66% |
Apr. 25 | Transcript : Aldeyra Therapeutics, Inc. - Special Call | |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Financials (USD)
Sales 2024 * | 24.88M | Sales 2025 * | 32.7M | Capitalization | 234M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -24M | EV / Sales 2024 * | 9.41 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.16 x |
P/E ratio 2024 * |
-31.3
x | P/E ratio 2025 * |
-10.6
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.39% |
Latest transcript on Aldeyra Therapeutics, Inc.
1 day | +6.60% | ||
1 week | +7.42% | ||
Current month | +6.60% | ||
1 month | +28.44% | ||
3 months | +34.19% | ||
6 months | +145.61% | ||
Current year | +19.66% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Brady
CEO | Chief Executive Officer | 52 | 05-08-31 |
Bruce Greenberg
DFI | Director of Finance/CFO | 56 | 19-11-30 |
Caitlin Pazzano
PRN | Corporate Officer/Principal | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 58 | 09-04-30 |
Martin Joyce
BRD | Director/Board Member | 70 | 13-09-30 |
Ben Bronstein
BRD | Director/Board Member | 74 | 10-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +1.32% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 4.2 | +6.60% | 539,262 |
24-04-30 | 3.94 | -2.72% | 273,896 |
24-04-29 | 4.05 | +3.05% | 393,326 |
24-04-26 | 3.93 | -0.25% | 267,876 |
24-04-25 | 3.94 | 0.00% | 462,606 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.66% | 234M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- ALDX Stock